Skip to main content

Table 4 Clinical characteristics and bone status of the 12 patients with severe BMD reduction.

From: Bone and body composition analyzed by Dual-energy X-ray Absorptiometry (DXA) in clinical and nutritional evaluation of young patients with Cystic Fibrosis: a cross-sectional study

Patient

gender

age

Height

Z score

BMI

Z score

FEV1%

Lumbar spine

BMD

Z score

Lumbar spine BMAD (g/cm3)

Additional causes

of BMD reduction

1

female

18

-2.95

-2.30

29

-4.8

0.14

Severe bilial cirrhosis, CFRD

2

male

13

-2.42

-1.22

80.5

-4

0.12

Patient living in a developing country, liver disease, CFRD

3

female

15

-1.75

-2.01

93.4

-4

0.12

Late CF diagnosis (14 yrs), celiac disease, CFRD

4

male

10

-1.22

1.35

18

-3.9

0.11

Right lung exeresis at age 4

5

female

15

-2.7

0,25

84,8

-3.2

0.13

Short bowel syndrome

6

male

13

-1.1

0,11

99,3

-2,7

0,12

Poor compliance

7

male

13

0.03

-0.48

102,9

-2.5

0.12

Poor compliance

8

female

11

-1.52

1.26

100

-2.3

0.12

Cow milk allergy

9

male

11

-0.24

-0.80

105.2

-2.3

0,12

Low social condition

10

female

9

+0.2

0.84

98

-2.2

0.11

No identified cause

11

female

7

-1.11

-0.26

98.1

-2.1

0. 11

No identified cause

12

male

11

-0.98

-0.89

56.3

-2.1

0.12

Prolonged steroid therapy for ABPA, CFRD

  1. CFRD = Cystic Fibrosis Related Diabetes; ABPA = Allergic BronchoPulmonary Aspergillosis